Regeneron Pharmaceuticals, Inc. (#REGN) | Moderated by Josh Schimmer and Olivia Brayer

We had the opportunity to sit with REGN’s legendary george yancopoulos (President, CSO, Board Member.) We discussed his views on the opportunities and challenges ahead for Regeneron and biotech in general. The company brings a unique and differentiated approach to some of the most challenging and seemingly competitive aspects of drug development, and we talked about what gives REGN the confidence and ability to thrive in such settings.

#Cantor #CantorFitzgerald #CantorHealthcare #CantorGlobalHealthcare2023